AIM Power

The goal of this real-world, multi-center, randomized, outpatient study is to assess the effectiveness of the Biofourmis cloud based BiovitalsHFTM Clinical Decision Support Platform to recommend optimal titration of Guideline-Directed Medical Therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) subjects.
Contact phone
Principal investigator
Chad Link, D.O.
Trial Category
Heart & Vascular
Trial SubCategory
Heart Failure